Workflow
MarketWatch
icon
Search documents
Structural drivers point to higher long-term bond yields — no matter what the Fed does, says this strategist.
MarketWatch· 2025-09-10 11:45
Core Viewpoint - Gavekal recommends a barbell strategy for bond investments, suggesting a combination of 2-year and 30-year debt while avoiding the intermediate maturities known as the "belly" of the curve [1] Group 1 - The barbell approach allows investors to balance risk and return by holding both short-term and long-term bonds [1] - This strategy is designed to mitigate interest rate risk while capturing yield from both ends of the maturity spectrum [1] - The recommendation reflects a broader market sentiment regarding the current economic environment and interest rate outlook [1]
Beyond the Fed and AI: Five-star manager offers small-cap stock picks that could be giants.
MarketWatch· 2025-09-10 11:00
Core Viewpoint - The current market conditions may favor larger companies acquiring smaller ones, suggesting a potential shift in the investment landscape that warrants further examination [1] Group 1 - Smaller companies are increasingly seen as potential acquisition targets by larger firms [1] - The investment space is being recommended for a second look due to these dynamics [1]
Tesla is losing U.S. market share. And that's in the middle of an EV boom.
MarketWatch· 2025-09-10 10:00
Core Insights - Tesla Inc.'s share of the U.S. electric vehicle (EV) market has decreased to its lowest level on record, indicating a potential loss of its competitive edge in the rapidly growing EV sector [1] Market Performance - Despite a significant boom in overall EV sales in the U.S., Tesla's market share has declined, suggesting challenges in maintaining its leading position [1] - The decline in market share occurs amidst increasing competition from other automakers entering the EV market, which may be impacting Tesla's sales performance [1]
Weight-loss drug manufacturer Novo Nordisk cuts 9000 jobs — and its profit forecast
MarketWatch· 2025-09-10 08:47
Core Viewpoint - The new CEO Mike Doustdar is implementing a significant restructuring of the company, focusing on diabetes and anti-obesity drugs while incurring substantial costs in the process [1] Group 1 - The company is undergoing a restructuring to prioritize its efforts in diabetes and anti-obesity drug development [1] - The restructuring is characterized by a "kitchen-sinking" approach, indicating a comprehensive write-off of costs associated with this transition [1]
Judge rules Lisa Cook can stay at the Fed. She'll vote at this month's rate-setting meeting.
MarketWatch· 2025-09-10 02:13
Core Points - A judge has ruled that Federal Reserve governor Lisa Cook will remain in her position for the central bank's upcoming meeting on September 16-17, which will determine interest rates [1] - This ruling represents a setback for President Donald Trump's attempt to remove Cook based on allegations of mortgage fraud [1]
Klarna prices IPO well above expected range, raising $1.37 billion
MarketWatch· 2025-09-10 00:39
Core Viewpoint - Klarna's IPO was priced at $40, exceeding the anticipated range of $35 to $37 [1] Group 1 - The IPO pricing indicates strong investor demand for Klarna's shares [1] - The pricing above the expected range suggests positive market sentiment towards the company [1]
Trump aims to curb direct-to-consumer ads for drugs. Hims & Hers Health could be targeted.
MarketWatch· 2025-09-09 23:12
Core Viewpoint - The Trump administration has introduced an executive action to restrict direct-to-consumer advertising for pharmaceuticals, responding to concerns raised by recent developments in the industry [1] Group 1: Executive Action Details - The executive action aims to limit the ability of pharmaceutical companies to advertise directly to consumers, which officials believe could lead to more informed healthcare decisions [1] - This move is part of a broader strategy to address rising drug prices and improve transparency in the pharmaceutical industry [1] Group 2: Industry Impact - The action is expected to have significant implications for companies engaged in direct-to-consumer marketing, particularly those like Hims & Hers Health, which have been prominent in this space [1] - Industry officials are concerned that such restrictions could hinder innovation and access to information for consumers [1]
GameStop posts fifth straight quarterly profit, thanks to a big sales jump
MarketWatch· 2025-09-09 21:04
Core Insights - The company reported a 22% increase in sales, indicating strong revenue growth [1] - This marks the fifth consecutive quarter of profitability for the company, showcasing consistent financial performance [1] - Following the earnings report, the stock price rose more than 5% in after-hours trading, reflecting positive investor sentiment [1]
Oracle's stock surges toward best day in years. These huge numbers explain why.
MarketWatch· 2025-09-09 20:51
Core Insights - The latest earnings and revenue numbers for Oracle fell short of expectations, but the company highlighted significant new multibillion-dollar deals and optimistic cloud projections [1] Financial Performance - Oracle's recent earnings report indicated that the company did not meet revenue expectations, suggesting potential challenges in its current financial performance [1] Strategic Outlook - Despite the earnings miss, Oracle's focus on new multibillion-dollar deals indicates a strategic shift towards expanding its market presence and revenue streams [1] - The company provided strong projections for its cloud services, signaling confidence in future growth opportunities within this segment [1]
Nvidia and its Big Tech peers have $1 trillion to spend. What should they do with it?
MarketWatch· 2025-09-09 19:32
Core Insights - The combined operating cash flow and net cash of the "Magnificent Seven" could exceed $1 trillion by the end of the year according to HSBC analysts [1] Company Spending Recommendations - Analysts have suggestions on how some of the companies within the "Magnificent Seven" could and should allocate their cash [1]